GLENMEDE TRUST CO NA - Valeant Pharmaceuticals ownership

Back to all holdings Add to watchlist

Valeant Pharmaceuticals's ticker is VRX and the CUSIP is 91911X104. A total of 1 filers reported holding Valeant Pharmaceuticals in Q4 2008. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of Valeant Pharmaceuticals
ValueSharesWeighting
Q2 2009$321,000
+44.6%
12,4960.0%0.08%
+20.6%
Q1 2009$222,000
-22.4%
12,4960.0%0.06%
-13.7%
Q4 2008$286,000
-20.6%
12,496
-29.0%
0.07%
+4.3%
Q3 2008$360,000
+36.9%
17,590
-14.4%
0.07%
+75.0%
Q1 2008$263,000–20,552–0.04%–
 Download
Other shareholders

There were no reported owners of Valeant Pharmaceuticals in Q4 2008.

NameSharesValueWeighting ↓
View complete list of Valeant Pharmaceuticals shareholders